Logo image of WAH.DE

WOLFTANK GROUP AG (WAH.DE) Stock Fundamental Analysis

Europe - FRA:WAH - AT0000A25NJ6 - Common Stock

6.85 EUR
-0.15 (-2.14%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

2

Overall WAH gets a fundamental rating of 2 out of 10. We evaluated WAH against 41 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of WAH have multiple concerns. WAH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year WAH has reported negative net income.
WAH had negative earnings in each of the past 5 years.
In multiple years WAH reported negative operating cash flow during the last 5 years.
WAH.DE Yearly Net Income VS EBIT VS OCF VS FCFWAH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

WAH's Return On Assets of -2.96% is on the low side compared to the rest of the industry. WAH is outperformed by 60.98% of its industry peers.
WAH's Return On Equity of -18.21% is on the low side compared to the rest of the industry. WAH is outperformed by 68.29% of its industry peers.
With a Return On Invested Capital value of 2.93%, WAH perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
Industry RankSector Rank
ROA -2.96%
ROE -18.21%
ROIC 2.93%
ROA(3y)-3.58%
ROA(5y)-23.74%
ROE(3y)-16.82%
ROE(5y)-109.66%
ROIC(3y)N/A
ROIC(5y)N/A
WAH.DE Yearly ROA, ROE, ROICWAH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

1.3 Margins

WAH has a Operating Margin of 1.85%. This is comparable to the rest of the industry: WAH outperforms 48.78% of its industry peers.
The Gross Margin of WAH (69.45%) is better than 75.61% of its industry peers.
In the last couple of years the Gross Margin of WAH has declined.
Industry RankSector Rank
OM 1.85%
PM (TTM) N/A
GM 69.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13%
GM growth 5Y-2.2%
WAH.DE Yearly Profit, Operating, Gross MarginsWAH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAH is destroying value.
WAH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WAH has more shares outstanding
The debt/assets ratio for WAH is higher compared to a year ago.
WAH.DE Yearly Shares OutstandingWAH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
WAH.DE Yearly Total Debt VS Total AssetsWAH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 1.87 indicates that WAH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.87, WAH is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that WAH is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.49, WAH is doing good in the industry, outperforming 70.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 1.87
ROIC/WACC0.48
WACC6.05%
WAH.DE Yearly LT Debt VS Equity VS FCFWAH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.34 indicates that WAH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.34, WAH perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
WAH has a Quick Ratio of 1.10. This is a normal value and indicates that WAH is financially healthy and should not expect problems in meeting its short term obligations.
WAH has a Quick ratio (1.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.1
WAH.DE Yearly Current Assets VS Current LiabilitesWAH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

5

3. Growth

3.1 Past

WAH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.67%.
WAH shows a strong growth in Revenue. In the last year, the Revenue has grown by 86.06%.
Measured over the past years, WAH shows a quite strong growth in Revenue. The Revenue has been growing by 14.27% on average per year.
EPS 1Y (TTM)-22.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.45%
Revenue 1Y (TTM)86.06%
Revenue growth 3Y35.33%
Revenue growth 5Y14.27%
Sales Q2Q%106.41%

3.2 Future

WAH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.82% yearly.
Based on estimates for the next years, WAH will show a quite strong growth in Revenue. The Revenue will grow by 12.96% on average per year.
EPS Next Y-29.41%
EPS Next 2Y-7.82%
EPS Next 3Y22.61%
EPS Next 5Y31.82%
Revenue Next Year40.15%
Revenue Next 2Y24.19%
Revenue Next 3Y18.37%
Revenue Next 5Y12.96%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
WAH.DE Yearly Revenue VS EstimatesWAH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
WAH.DE Yearly EPS VS EstimatesWAH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

WAH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 30.99, which means the current valuation is very expensive for WAH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of WAH is on the same level as its industry peers.
WAH is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 30.99
WAH.DE Price Earnings VS Forward Price EarningsWAH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as WAH.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.86
WAH.DE Per share dataWAH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

WAH's earnings are expected to grow with 22.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.82%
EPS Next 3Y22.61%

0

5. Dividend

5.1 Amount

WAH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WOLFTANK GROUP AG

FRA:WAH (9/12/2025, 7:00:00 PM)

6.85

-0.15 (-2.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners23.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap36.17M
Analysts86.67
Price Target17.32 (152.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.99
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB 5.25
EV/EBITDA 7.86
EPS(TTM)-0.65
EYN/A
EPS(NY)0.22
Fwd EY3.23%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.49
BVpS3.56
TBVpS1.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.96%
ROE -18.21%
ROCE 4.16%
ROIC 2.93%
ROICexc 3.87%
ROICexgc 5.5%
OM 1.85%
PM (TTM) N/A
GM 69.45%
FCFM N/A
ROA(3y)-3.58%
ROA(5y)-23.74%
ROE(3y)-16.82%
ROE(5y)-109.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13%
GM growth 5Y-2.2%
F-ScoreN/A
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.1
Altman-Z 1.87
F-ScoreN/A
WACC6.05%
ROIC/WACC0.48
Cap/Depr(3y)118.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.45%
EPS Next Y-29.41%
EPS Next 2Y-7.82%
EPS Next 3Y22.61%
EPS Next 5Y31.82%
Revenue 1Y (TTM)86.06%
Revenue growth 3Y35.33%
Revenue growth 5Y14.27%
Sales Q2Q%106.41%
Revenue Next Year40.15%
Revenue Next 2Y24.19%
Revenue Next 3Y18.37%
Revenue Next 5Y12.96%
EBIT growth 1Y807.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year324.11%
EBIT Next 3Y84.53%
EBIT Next 5Y38.59%
FCF growth 1Y-2.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2350.13%
OCF growth 3YN/A
OCF growth 5Y28.14%